{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:56:31Z","timestamp":1773766591146,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1124\/jpet.113.206847","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T04:14:25Z","timestamp":1382069665000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A Novel and Potent Inhibitor of Dimethylarginine Dimethylaminohydrolase: A Modulator of Cardiovascular Nitric Oxide"],"prefix":"10.1016","volume":"348","author":[{"given":"Yohannes T.","family":"Ghebremariam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Erlanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.206847_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.113.206847_bib2","first-page":"303","article-title":"Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis","volume":"44","author":"Batra","year":"2007","journal-title":"Indian J Biochem Biophys"},{"key":"10.1124\/jpet.113.206847_bib3","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/ja002142z","article-title":"Identification of a slow tight-binding inhibitor of 3-deoxy-D-manno-octulosonic acid 8-phosphate synthase","volume":"122","author":"Birck","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.113.206847_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/3228","article-title":"Discovery of the nitric oxide signaling pathway and targets for drug development","volume":"14","author":"Bryan","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1124\/jpet.113.206847_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.05722-11","article-title":"PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus","volume":"56","author":"Chamoun","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.113.206847_bib6","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI115481","article-title":"Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator","volume":"88","author":"Cooke","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.113.206847_bib7","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/01.CIR.88.5.2451","article-title":"Cytoprotective effects of nitric oxide","volume":"88","author":"Cooke","year":"1993","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.206847_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ab.2011.05.029","article-title":"Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis","volume":"416","author":"Copeland","year":"2011","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.113.206847_bib9","series-title":"Antiangiogenic Cancer Therapy","author":"Davis","year":"2008"},{"key":"10.1124\/jpet.113.206847_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bi00698a001","article-title":"Cyanylation of sulfhydryl groups by 2-nitro-5-thiocyanobenzoic acid: high-yield modification and cleavage of peptides at cysteine residues","volume":"13","author":"Degani","year":"1974","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.113.206847_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.113.206847_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.RES.73.2.217","article-title":"Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease","volume":"73","author":"Dinerman","year":"1993","journal-title":"Circ Res"},{"key":"10.1124\/jpet.113.206847_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.113.206847_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1124\/jpet.113.206847_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1465-9921-6-58","article-title":"Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury","volume":"6","author":"Genovese","year":"2005","journal-title":"Respir Res"},{"key":"10.1124\/jpet.113.206847_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/1087057112441521","article-title":"Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening","volume":"17","author":"Ghebremariam","year":"2012","journal-title":"J Biomol Screen"},{"key":"10.1124\/jpet.113.206847_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.206847_bib18","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.bmcl.2007.04.095","article-title":"Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysis","volume":"17","author":"Hartzoulakis","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.113.206847_bib19","doi-asserted-by":"crossref","first-page":"15744","DOI":"10.1073\/pnas.0908733106","article-title":"CKIepsilon\/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock","volume":"106","author":"Isojima","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.113.206847_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1349-7006.1997.tb00462.x","article-title":"NG-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model","volume":"88","author":"Iwasaki","year":"1997","journal-title":"Jpn J Cancer Res"},{"key":"10.1124\/jpet.113.206847_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4127","article-title":"The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis","volume":"229","author":"Janssen","year":"2013","journal-title":"J Pathol"},{"key":"10.1124\/jpet.113.206847_bib22","first-page":"82","article-title":"Evidence-based therapies for sepsis care in the emergency department: striking a balance between feasibility and necessity","volume":"13","author":"Jones","year":"2006","journal-title":"Acad Emerg Med"},{"key":"10.1124\/jpet.113.206847_bib23","first-page":"H1038","article-title":"Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway","volume":"259","author":"Julou-Schaeffer","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.206847_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.chembiol.2009.02.010","article-title":"Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets","volume":"16","author":"Kal\u00e9n","year":"2009","journal-title":"Chem Biol"},{"key":"10.1124\/jpet.113.206847_bib25","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1167\/iovs.07-0089","article-title":"Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization","volume":"49","author":"Kiuchi","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.113.206847_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.bjc.6600518","article-title":"Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis","volume":"87","author":"Kostourou","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.113.206847_bib27","first-page":"4960","article-title":"Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging","volume":"63","author":"Kostourou","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.113.206847_bib28","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1016\/j.bmc.2008.10.058","article-title":"Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: alkenyl-amidines as new leads","volume":"16","author":"Kotthaus","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.113.206847_bib29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.113.206847_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1468-2982.1998.1801027.x","article-title":"Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks","volume":"18","author":"Lassen","year":"1998","journal-title":"Cephalalgia"},{"key":"10.1124\/jpet.113.206847_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrd3358","article-title":"The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis","volume":"10","author":"Leiper","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.206847_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","article-title":"Disruption of methylarginine metabolism impairs vascular homeostasis","volume":"13","author":"Leiper","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/jpet.113.206847_bib33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/1087057111417712","article-title":"A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1","volume":"16","author":"Linsky","year":"2011","journal-title":"J Biomol Screen"},{"key":"10.1124\/jpet.113.206847_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/ml2000824","article-title":"Screening for dimethylarginine dimethylaminohydrolase inhibitors reveals ebselen as a bioavailable inactivator","volume":"2","author":"Linsky","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/jpet.113.206847_bib35","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1016\/j.bmc.2012.07.022","article-title":"Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase","volume":"20","author":"Linsky","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.113.206847_bib36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00003246-199305000-00021","article-title":"Role of nitric oxide in the hemodynamic changes of sepsis","volume":"21","author":"Lorente","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.113.206847_bib37","doi-asserted-by":"crossref","first-page":"9730","DOI":"10.1073\/pnas.90.20.9730","article-title":"Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide","volume":"90","author":"Lowenstein","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.113.206847_bib38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1152\/physrev.1990.70.3.701","article-title":"Nitrogen metabolism and ornithine cycle function","volume":"70","author":"Meijer","year":"1990","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.113.206847_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/jo902327n","article-title":"Efficient synthesis of pyrimido[1,2-c] [1,3]benzothiazin-6-imines and related tricyclic heterocycles by S(N)Ar-type C-S, C-N, or C-O bond formation with heterocumulenes","volume":"75","author":"Mizuhara","year":"2010","journal-title":"J Org Chem"},{"key":"10.1124\/jpet.113.206847_bib40","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1039\/c2ob25904d","article-title":"Concise synthesis and anti-HIV activity of pyrimido[1,2-c][1,3]benzothiazin-6-imines and related tricyclic heterocycles","volume":"10","author":"Mizuhara","year":"2012","journal-title":"Org Biomol Chem"},{"key":"10.1124\/jpet.113.206847_bib41","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1016\/j.bmc.2012.08.030","article-title":"Structure-activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives for potent anti-HIV agents","volume":"20","author":"Mizuhara","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.113.206847_bib42","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.bmc.2013.01.016","article-title":"Design and synthesis of biotin- or alkyne-conjugated photoaffinity probes for studying the target molecules of PD 404182","volume":"21","author":"Mizuhara","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.113.206847_bib43","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","article-title":"Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase","volume":"25","author":"M\u00fcnzel","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.113.206847_bib44","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/ATVBAHA.112.300232","article-title":"Genetic and pharmacological inhibition of dimethylarginine dimethylaminohydrolase 1 is protective in endotoxic shock","volume":"32","author":"Nandi","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.113.206847_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nurt.2010.03.006","article-title":"Nitric oxide-related drug targets in headache","volume":"7","author":"Olesen","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.113.206847_bib46","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems","volume":"293","author":"Palm","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.113.206847_bib47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.02.00682001a","article-title":"Human alveolar epithelial cells induce nitric oxide synthase-2 expression in alveolar macrophages","volume":"19","author":"Pechkovsky","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.206847_bib48","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1476-5381.1996.tb15557.x","article-title":"Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine","volume":"118","author":"Pfeiffer","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.206847_bib49","doi-asserted-by":"crossref","first-page":"87ra53","DOI":"10.1126\/scitranslmed.3001725","article-title":"The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis","volume":"3","author":"Pullamsetti","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1124\/jpet.113.206847_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1359-6446(01)01804-9","article-title":"LPS inhibitors: key to overcoming multidrug-resistant bacteria?","volume":"6","author":"Sansom","year":"2001","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.113.206847_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cell.2011.08.035","article-title":"Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice","volume":"147","author":"Seimetz","year":"2011","journal-title":"Cell"},{"key":"10.1124\/jpet.113.206847_bib52","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine","volume":"104","author":"St\u00fchlinger","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/jpet.113.206847_bib53","doi-asserted-by":"crossref","first-page":"9420","DOI":"10.1074\/jbc.M610983200","article-title":"Stabilization of hyperactive dihydrofolate reductase by cyanocysteine-mediated backbone cyclization","volume":"282","author":"Takahashi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.206847_bib54","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3892\/ijo.2013.2011","article-title":"Effect of a nitric oxide synthase inhibitor and a CXC chemokine receptor-4 antagonist on tumor growth and metastasis in a xenotransplanted mouse model of adenoid cystic carcinoma of the oral floor","volume":"43","author":"Takaoka","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.113.206847_bib55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/oxfordjournals.jbchem.a022053","article-title":"Cyanocysteine-mediated molecular dissection of dihydrofolate reductase: occurrence of intra- and inter-molecular reactions forming a peptide bond","volume":"123","author":"Takenawa","year":"1998","journal-title":"J Biochem"},{"key":"10.1124\/jpet.113.206847_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.RES.0000052990.68216.EF","article-title":"Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase","volume":"92","author":"Ueda","year":"2003","journal-title":"Circ Res"},{"key":"10.1124\/jpet.113.206847_bib57","first-page":"1303","article-title":"The DDAH\/NOS pathway in human prostatic cancer cell lines: antiangiogenic effect of L-NAME","volume":"39","author":"Vanella","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.113.206847_bib58","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1021\/bi9007098","article-title":"Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide","volume":"48","author":"Wang","year":"2009","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.113.206847_bib59","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.CCM.0000085178.80226.0B","article-title":"Long-term mortality and medical care charges in patients with severe sepsis","volume":"31","author":"Weycker","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.113.206847_bib60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/carcin\/19.5.711","article-title":"The multifaceted roles of nitric oxide in cancer","volume":"19","author":"Wink","year":"1998","journal-title":"Carcinogenesis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.206847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:09:28Z","timestamp":1739995768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524271871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022356524271871"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.206847","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel and Potent Inhibitor of Dimethylarginine Dimethylaminohydrolase: A Modulator of Cardiovascular Nitric Oxide","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.206847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}